Navigation Links
Orexigen(R) Therapeutics Schedules March 9, 2010 Webcast Discussion of Financial Results for the Fourth Quarter and Year Ended December 31, 2009
Date:3/4/2010

SAN DIEGO, March 4 /PRNewswire-FirstCall/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, will announce its fourth quarter and year ended December 31, 2009 financial results on Tuesday, March 9, 2010 before the markets open. The announcement will be followed by a live webcast and conference call at 8:00 a.m. Eastern time.

Orexigen management will host the call and webcast to discuss financial results and recent business highlights. The live call may be accessed by phone by calling (866) 730-5769 (domestic) or (857) 350-1593 (international), participant
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Orexigen(R) Therapeutics Appoints Peter Honig, M.D. to Board of Directors
2. Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
3. Orexigen(R) Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635
4. Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
5. Orexigen(R) Therapeutics to Speak at Lazard Capital Markets Healthcare Conference
6. Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results
7. Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society
8. Orexigen(R) Therapeutics Schedules September 30, 2009 Teleconference and Webcast to Discuss Phase 2b Trial Results From Second Obesity Drug Candidate, Empatic(TM)
9. Orexigen(R) Therapeutics Schedules July 20, 2009 Teleconference and Webcast Discussion of Contrave(R) Phase 3 Results
10. Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team
11. Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... MINNETONKA, Minn. , Sept. 23, 2014   MedNet ... clinical study management systems, is pleased to announce that it ... for Clinical Data Management (SCDM) Annual Conference, to be held ... Las Vegas , Nevada. MedNet team members, in conjunction ... Partner Organizations who will also be in attendance, will ...
(Date:9/23/2014)... Fla. and DUBLIN ... (OTC-BB: TNIB) ("we" or the "Company"), a biotechnology ... therapies for autoimmune diseases in emerging nations, today ... approved our common stock for DTC,s Deposit and ... Automated Securities Transfer Service ("FAST") transfer agent as ...
(Date:9/23/2014)... CHICAGO , Sept. 23, 2014  Hill-Rom (NYSE: ... agreement with Providence Health ( Renton, WA ... new agreement expands the companies, existing relationship as Hill-Rom ... Maternal, and Bariatric capital bed frame and surface products. ... largest health systems in the U.S.  It operates 34 ...
Breaking Medicine Technology:MedNet Solutions - Proud To Sponsor The SCDM 2014 Annual Conference 2TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 2TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 3TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 4Hill-Rom Announces Seven-Year, Sole-Source Contract with Providence Health 2
... Stage Invention is Advancement toward Artificial Lungs, ... those suffering from lung ailments take note: Innovation ... from Battelle has earned a,patent for generating oxygen ... technology creates oxygen and controls carbon dioxide using ...
... Data ... Presentations -, SAN FRANCISCO, Sept. 24 ... development of,compounds for the treatment of cardiovascular disease, announced today that,it has ... study, including the sub-study of patients who received an,additional 3 months of ...
Cached Medicine Technology:Battelle Scientists Named on Patent for Making Oxygen From Light and Water 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Acute Coronary Syndrome (ACS) Trial 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Acute Coronary Syndrome (ACS) Trial 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Acute Coronary Syndrome (ACS) Trial 4
(Date:9/23/2014)... 23, 2014 Grinnell Mutual seeks ... projects in the Midwest. Working Together Making It ... non-profit organizations with projects positively impacting their communities. ... marketplace make their communities a better places,” said ... Community Relations Barb Baker. “Their leadership—as coaches, as ...
(Date:9/23/2014)... News) -- The number of ,rogue, wholesale distributors ... so doctors need to be vigilant when purchasing ... Tuesday. In a statement, the agency said ... launched a program to educate doctors and other ... purchasing procedures. The program aims to protect patients ...
(Date:9/23/2014)... A national report showing the benefits of ... for providing Medicaid services was released today by ... report, "Why Congress Must Save the Medicaid Primary ... to Ensure Access to Life-Saving Primary Care Will ... Medicaid patients, access to internists and pediatricians (and ...
(Date:9/23/2014)... September 23, 2014 Trevera provides ... market. Included are Oracle Managed Services , ... supports all versions of Oracle E-Business Databases ... , Trevera has announced a significant enhancement ... need help with their software technology management, project ...
(Date:9/23/2014)... 2014 SOURCE: Solutions from Our ... were made to Rimidi Diabetes and ... with business solutions to challenges faced by patients and ... collaboration between The Hitachi Foundation, Village ... entrepreneurs with the investment capital, mentoring, and support needed ...
Breaking Medicine News(10 mins):Health News:Grinnell Mutual Invites Submissions for Innovative, Collaborative Local Projects in Its Second Annual Working Together Making It Better Promotion 2Health News:Unless Congress acts, patients may soon lose access to primary care 2Health News:Unless Congress acts, patients may soon lose access to primary care 3Health News:Trevera, Inc adds Management Support to Services 2Health News:Trevera, Inc adds Management Support to Services 3Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 2Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 3Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 4Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 5
... Cardiac Science (Nasdaq: CSCX ), a ... informatics products, today announced today that it will present ... at the Ritz Carlton Laguna Nigel. John Hinson, president ... strategy and recent financial results during the Company,s presentation ...
... & Sullivan to Host Quarterly Analyst Briefing on ... The Chemicals Group at Frost & Sullivan ... Analyst Briefing Presentation on Medical Trends Impacting the ... Thursday, 26 February, 2009 at 3 p.m. GMT.(Logo: ...
... 17 Microscopic insects called dust mites are the leading cause of ... indoor allergens are pet dander and dust mold. Dust mites are ... carpets by the tens of millions. There can be as many ... written by Jay DeFoore titled " Is your ...
... Arkansas-based electronic medical transcription and document management software provider, will ... , ... Little Rock, AR (PRWeb) ... document management software provider eMedDox (formerly Health Data Services, LLC) ...
... getting pharmaceutical companies more directly involved in helping patients in need ... the YourRxCard free prescription drug card. The company also announced new ... , privately funded by Group Net LLC. , ... ...
... doctors, pharmacists and other healthcare professionals a free, unique medical ... For posting occasional prescription drug information and insight on PrescriptionDrug-Info.com, ... inbound links to the URL of their choice. , ... ...
Cached Medicine News:Health News:Cardiac Science to Present at the Roth 21st Annual OC Growth Stock Conference 2Health News:Cardiac Science to Present at the Roth 21st Annual OC Growth Stock Conference 3Health News:Frost & Sullivan Helps You Know Your End-Market: Medical Trends Impacting the Chemicals and Materials Markets 2Health News:Frost & Sullivan Helps You Know Your End-Market: Medical Trends Impacting the Chemicals and Materials Markets 3Health News:Are You Really Sleeping on Clean Bedsheets? 2Health News:New Website Coming Soon for Electronic Medical Transcription Company 2Health News:Patient Savings on Prescription Drugs Reach Record High for 2008, Goal Announced for 2009 2Health News:Patient Savings on Prescription Drugs Reach Record High for 2008, Goal Announced for 2009 3Health News:Patient Savings on Prescription Drugs Reach Record High for 2008, Goal Announced for 2009 4Health News:Patient Savings on Prescription Drugs Reach Record High for 2008, Goal Announced for 2009 5Health News:Patient Savings on Prescription Drugs Reach Record High for 2008, Goal Announced for 2009 6Health News:Prescription Drug Information Site Offers Free Medical Marketing Opportunity to Healthcare Professionals 2Health News:Prescription Drug Information Site Offers Free Medical Marketing Opportunity to Healthcare Professionals 3
The Bledsoe Flatform Boot is designed with a flat innersole for procedures where toe dorsiflexion is not permissible....
The Bledsoe Achilles Boot saves time by eliminating casting series required to stretch the achilles tendon during rehab....
... Cronin, Inc. is a ... Footwear, Orthopedic Softgoods, and ... Our products are of ... available in the USA ...
... Bauerfeind™ AchilloTrain® The viscoelastic insert runs ... application of pressure and targeted intermittent ... reduction of painful irritation of the ... integrated viscoelastic heel wedge (raises heel ...
Medicine Products: